Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.271951792721248e-56,47.668371212121215,6107.468395822663,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.815855378163744e-54,0,0,62
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.8475961618542385e-43,38.70804552972079,3758.058132046642,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'ATP5PO']",1.0271394242781358e-40,0,0,49
3,Nonalcoholic fatty liver disease WP4396,9.022940831708468e-31,15.920656634746923,1101.3968779049019,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'INSR', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",9.022940831708468e-29,0,0,46
4,Oxidative phosphorylation WP623,2.074449249642651e-22,27.832402943415378,1389.593289980006,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'ATP5PO']",1.5558369372319885e-20,0,0,27
5,Mitochondrial complex I assembly model OXPHOS system WP4324,8.176887117651097e-20,26.50502854036423,1164.906350047718,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",4.906132270590658e-18,0,0,24
6,Mitochondrial CIV Assembly WP4922,1.7476744372778647e-12,23.565217391304348,637.9748881203599,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14']",8.738372186389324e-11,0,0,15
7,Mitochondrial complex III assembly WP4921,1.6152106844847715e-07,27.9553264604811,437.18301397767425,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",6.9223315049347344e-06,0,0,8
8,Cellular Proteostasis WP4918,7.86511048207161e-06,69.55555555555556,817.4915897641824,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.00029494164307768535,0,0,5
9,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0011672591337086365,41.59114139693356,280.8690080002909,"['COX8A', 'GSTP1', 'COX5A']",0.03890863779028789,0,0,3
10,Selenium Micronutrient Network WP15,0.003938723386451266,3.59516683294535,19.90607428235786,"['SELENOM', 'PRDX5', 'GPX4', 'INSR', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH']",0.11816170159353798,0,0,8
11,Nanomaterial induced apoptosis WP2507,0.004647670453319301,7.929790346172599,42.59398992787464,"['CASP9', 'ENDOG', 'BAX', 'CYCS']",0.12420987924238254,0,0,4
12,mRNA Processing WP411,0.004968395169695302,3.13644578313253,16.637773452388057,"['SF3B5', 'LSM7', 'SNRPG', 'CD2BP2', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'SRSF9']",0.12420987924238254,0,0,9
13,Pyrimidine metabolism WP4022,0.005705644192813629,3.059569287603375,15.806650928328521,"['POLR1B', 'POLE3', 'NME2', 'ENPP1', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.13166871214185297,0,0,9
14,Eukaryotic Transcription Initiation WP405,0.011395809902270418,4.339209401709402,19.415833879532357,"['GTF2A2', 'TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.2396832392758372,0,0,5
15,Cholesterol Biosynthesis Pathway WP197,0.01198416196379186,5.548805460750853,24.548854978074203,"['IDI1', 'NSDHL', 'MVK', 'MSMO1']",0.2396832392758372,0,0,4
16,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.01306910338123204,27.68027210884354,120.06330081919889,"['ELOB', 'ELOC']",0.24504568839810073,0,0,2
17,Serotonin Transporter Activity WP1455,0.024970987280597573,13.83843537414966,51.064388880367495,"['IL1R1', 'NOS1']",0.4068818305064701,0,0,2
18,Dual hijack model of Vif in HIV infection WP3300,0.024970987280597573,13.83843537414966,51.064388880367495,"['ELOB', 'ELOC']",0.4068818305064701,0,0,2
19,TP53 network WP1742,0.025769182598743105,5.9372110002433685,21.721737517600904,"['SUMO1', 'GADD45A', 'BAX']",0.4068818305064701,0,0,3
20,Non-small cell lung cancer WP4255,0.040375003798554965,2.6028467465753424,8.353952208268074,"['CASP9', 'EML4', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.5825271760027522,0,0,6
21,Apoptosis Modulation and Signaling WP1772,0.040899256134019256,2.3715014851692255,7.580844579030331,"['CASP9', 'ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'MAP3K14']",0.5825271760027522,0,0,7
22,MTHFR deficiency WP4288,0.042718659573535156,4.616695059625213,14.556991041914646,"['CASP9', 'CHKA', 'CYCS']",0.5825271760027522,0,0,3
23,Acute viral myocarditis WP4298,0.054730412896859676,2.6669953977646284,7.748517019814268,"['CASP9', 'ENDOG', 'CYCS', 'BAX', 'NOS1']",0.7138749508286044,0,0,5
24,TNF-alpha signaling pathway WP231,0.06734683305982472,2.249722325064791,6.069524509512734,"['CASP9', 'TRADD', 'BAX', 'TXN', 'HRAS', 'MAP3K14']",0.8110866643540369,0,0,6
25,Mitochondrial CII Assembly WP4920,0.06759055536283641,inf,inf,['SDHAF1'],0.8110866643540369,0,0,1
26,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.07608100019859856,3.4612436115843273,8.91601372061147,"['CASP9', 'BAX', 'NOS1']",0.8778576945992141,0,0,3
27,Folate Metabolism WP176,0.08444274977193734,2.6387128230131642,6.522057646631123,"['GPX4', 'INSR', 'NOS1', 'SLC19A1']",0.9048311247069672,0,0,4
28,Photodynamic therapy-induced unfolded protein response WP3613,0.08912270049613719,3.194600969728738,7.723718386754434,"['XBP1', 'DDIT3', 'PDIA6']",0.9048311247069672,0,0,3
29,Proteasome Degradation WP183,0.09252994353584908,2.235456299972429,5.320884440212864,"['PSMC5', 'H2AFZ', 'PSMA2', 'HLA-B', 'PSMB10']",0.9048311247069672,0,0,5
30,Cytosolic DNA-sensing pathway WP4655,0.09472395664219538,2.518461061123177,5.935479655379452,"['IRF3', 'TRADD', 'POLR2K', 'POLR2L']",0.9048311247069672,0,0,4
31,Glutathione metabolism WP100,0.09733848443041333,4.610544217687075,10.740543281599546,"['GPX4', 'IDH1']",0.9048311247069672,0,0,2
32,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.09733848443041333,4.610544217687075,10.740543281599546,"['IDI1', 'MVK']",0.9048311247069672,0,0,2
33,p38 MAPK Signaling Pathway WP400,0.10302335850616742,2.966050133852519,6.7412373645626396,"['TRADD', 'DDIT3', 'HRAS']",0.9048311247069672,0,0,3
34,Parkinson's disease pathway WP2371,0.10302335850616742,2.966050133852519,6.7412373645626396,"['CASP9', 'CYCS', 'PARK7']",0.9048311247069672,0,0,3
35,NO/cGMP/PKG mediated Neuroprotection WP4008,0.10556363121581284,2.4086659741801455,5.415744218992455,"['CASP9', 'CAMK2A', 'CYCS', 'NOS1']",0.9048311247069672,0,0,4
36,Type 2 papillary renal cell carcinoma WP4241,0.1177159567076989,2.7679727427597958,5.922024269277632,"['SETD2', 'ELOB', 'ELOC']",0.9349406660323323,0,0,3
37,Computational Model of Aerobic Glycolysis WP4629,0.11972797504786328,3.9514091350826046,8.386996222693332,"['LDHA', 'PFKM']",0.9349406660323323,0,0,2
38,Apoptosis WP254,0.12024120721850426,2.037456008044243,4.315852381832344,"['CASP9', 'IRF3', 'TRADD', 'CYCS', 'BAX']",0.9349406660323323,0,0,5
39,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.12881741958153897,2.2154266211604097,4.540204992819855,"['IDI1', 'NSDHL', 'MVK', 'MSMO1']",0.9349406660323323,0,0,4
40,Acetylcholine Synthesis WP528,0.13061996354727015,13.816638370118845,28.123259137746725,['CHKA'],0.9349406660323323,0,0,1
41,DNA damage response WP707,0.14117603097124057,2.129955368863219,4.169915268501365,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9349406660323323,0,0,4
42,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.14117603097124057,2.129955368863219,4.169915268501365,"['IFI27L2', 'CAMK2A', 'ETS1', 'HRAS']",0.9349406660323323,0,0,4
43,Apoptosis Modulation by HSP70 WP384,0.14321768769233195,3.4570578231292517,6.71840992510731,"['CASP9', 'CYCS']",0.9349406660323323,0,0,2
44,Unfolded protein response WP4925,0.14321768769233195,3.4570578231292517,6.71840992510731,"['XBP1', 'DDIT3']",0.9349406660323323,0,0,2
45,Oxidative Damage WP3941,0.14919908534498316,2.4417276280188394,4.645322647676036,"['CASP9', 'GADD45A', 'CYCS']",0.9349406660323323,0,0,3
46,Genotoxicity pathway WP4286,0.1539827935135874,2.050815320439894,3.836899941908648,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9349406660323323,0,0,4
47,miRNA regulation of DNA damage response WP1530,0.1539827935135874,2.050815320439894,3.836899941908648,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9349406660323323,0,0,4
48,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.1539827935135874,2.050815320439894,3.836899941908648,"['CASP9', 'BAX', 'NOS1', 'HRAS']",0.9349406660323323,0,0,4
49,Amyotrophic lateral sclerosis (ALS) WP2447,0.16584885994098716,2.3057921635434413,4.1427669466502195,"['CASP9', 'BAX', 'NOS1']",0.9349406660323323,0,0,3
50,Endometrial cancer WP4155,0.16720645118701497,1.977328132618235,3.5365027666659055,"['CASP9', 'GADD45A', 'BAX', 'HRAS']",0.9349406660323323,0,0,4
51,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.18081489754500613,1.9089090267153113,3.264771672344477,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9349406660323323,0,0,4
52,DNA Replication WP466,0.18301075265828112,2.1841656953286113,3.7091728339795798,"['RFC3', 'GMNN', 'UBA52']",0.9349406660323323,0,0,3
53,Glycolysis and Gluconeogenesis WP534,0.18301075265828112,2.1841656953286113,3.7091728339795798,"['LDHA', 'MPC2', 'PFKM']",0.9349406660323323,0,0,3
54,Modulators of TCR signaling and T cell activation WP5072,0.18301075265828112,2.1841656953286113,3.7091728339795798,"['NDUFB10', 'ELOB', 'MAP3K14']",0.9349406660323323,0,0,3
55,Effects of nitric oxide WP1995,0.1893954339043459,6.907470288624788,11.493465575719414,['NOS1'],0.9349406660323323,0,0,1
56,Gene regulatory network modelling somitogenesis  WP2854,0.1893954339043459,6.907470288624788,11.493465575719414,['RIPPLY2'],0.9349406660323323,0,0,1
57,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1893954339043459,6.907470288624788,11.493465575719414,['BAX'],0.9349406660323323,0,0,1
58,Peroxiredoxin 2 induced ovarian failure WP4873,0.1893954339043459,6.907470288624788,11.493465575719414,['BAX'],0.9349406660323323,0,0,1
59,Statin inhibition of cholesterol production WP430,0.19252496139841632,2.7649659863945577,4.55536292970464,"['APOC1', 'PLTP']",0.9349406660323323,0,0,2
60,Ebstein-Barr virus LMP1 signaling WP262,0.19252496139841632,2.7649659863945577,4.55536292970464,"['TRADD', 'MAP3K14']",0.9349406660323323,0,0,2
61,Ciliary landscape WP4352,0.21657998525305983,1.3721406623420962,2.0990944087375683,"['POM121', 'EXOSC4', 'NDUFA5', 'CAMK2A', 'CD2BP2', 'COPS7A', 'MYL6B', 'SNRPB2', 'COX6C', 'LSM4']",0.9349406660323323,0,0,10
62,DNA Mismatch Repair WP531,0.21792519019729611,2.5132962275819417,3.829266776373712,"['RFC3', 'POLE3']",0.9349406660323323,0,0,2
63,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.21792519019729611,2.5132962275819417,3.829266776373712,"['CASP9', 'BAX']",0.9349406660323323,0,0,2
64,Imatinib and Chronic Myeloid Leukemia WP3640,0.21792519019729611,2.5132962275819417,3.829266776373712,"['SPRED2', 'GADD45A']",0.9349406660323323,0,0,2
65,miRNA regulation of p53 pathway in prostate cancer WP3982,0.21792519019729611,2.5132962275819417,3.829266776373712,"['CASP9', 'BAX']",0.9349406660323323,0,0,2
66,MET in type 1 papillary renal cell carcinoma WP4205,0.2185981255191749,1.9756631783889025,3.004035925656347,"['RPL11', 'ETS1', 'HRAS']",0.9349406660323323,0,0,3
67,Melanoma WP4685,0.22362074481972832,1.7293088737201365,2.590165342822514,"['GADD45A', 'BAX', 'ETS1', 'HRAS']",0.9349406660323323,0,0,4
68,Nucleotide Excision Repair WP4753,0.23689204206371725,1.8856280006194828,2.7155885988212276,"['RFC3', 'POLE3', 'GTF2H5']",0.9349406660323323,0,0,3
69,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.2442036003399395,4.604414261460102,6.491086698655557,['RIPPLY2'],0.9349406660323323,0,0,1
70,BDNF-TrkB Signaling WP3676,0.2693557201408235,2.1261119832548405,2.788868698989633,"['HOMER1', 'HRAS']",0.9349406660323323,0,0,2
71,Fas ligand pathway and stress induction of heat shock proteins WP314,0.2693557201408235,2.1261119832548405,2.788868698989633,"['CASP9', 'CYCS']",0.9349406660323323,0,0,2
72,Gastric Cancer Network 2 WP2363,0.2693557201408235,2.1261119832548405,2.788868698989633,"['RFC3', 'SNURF']",0.9349406660323323,0,0,2
73,Histone Modifications WP2369,0.2693557201408235,2.1261119832548405,2.788868698989633,"['SETD2', 'SET']",0.9349406660323323,0,0,2
74,7q11.23 copy number variation syndrome WP4932,0.2736576892088399,1.4715402800509183,1.9069355906368508,"['ATP5PO', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9349406660323323,0,0,5
75,Signal transduction through IL1R WP4496,0.2951032937126897,1.9740038872691934,2.409133239912321,"['IL1R1', 'MAP3K14']",0.9349406660323323,0,0,2
76,Monoamine Transport WP727,0.2951032937126897,1.9740038872691934,2.409133239912321,"['IL1R1', 'NOS1']",0.9349406660323323,0,0,2
77,SARS-CoV-2 mitochondrial interactions WP5038,0.2951032937126897,1.9740038872691934,2.409133239912321,"['NDUFB9', 'IRF3']",0.9349406660323323,0,0,2
78,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.29531182496571734,3.452886247877759,4.21156631679909,['IDH1'],0.9349406660323323,0,0,1
79,Cytosine methylation WP3585,0.29531182496571734,3.452886247877759,4.21156631679909,['IDH1'],0.9349406660323323,0,0,1
80,Insulin signaling in adipocytes (diabetic condition) WP3635,0.29531182496571734,3.452886247877759,4.21156631679909,['INSR'],0.9349406660323323,0,0,1
81,Insulin signaling in adipocytes (normal condition) WP3634,0.29531182496571734,3.452886247877759,4.21156631679909,['INSR'],0.9349406660323323,0,0,1
82,Kennedy pathway from sphingolipids WP3933,0.29531182496571734,3.452886247877759,4.21156631679909,['CHKA'],0.9349406660323323,0,0,1
83,Leptin Insulin Overlap WP3935,0.29531182496571734,3.452886247877759,4.21156631679909,['INSR'],0.9349406660323323,0,0,1
84,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.29531182496571734,3.452886247877759,4.21156631679909,['VEGFB'],0.9349406660323323,0,0,1
85,Alzheimer's disease WP2059,0.2995984785705775,1.4946960612489624,1.8015752567477232,"['CASP9', 'ATP5MD', 'CYCS', 'NOS1']",0.9349406660323323,0,0,4
86,CAMKK2  Pathway WP4874,0.3207139493169011,1.8421768707482993,2.094933995014949,"['FIS1', 'NOS1']",0.9349406660323323,0,0,2
87,GABA receptor Signaling WP4159,0.3207139493169011,1.8421768707482993,2.094933995014949,"['SLC32A1', 'AP2M1']",0.9349406660323323,0,0,2
88,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.33096501134508854,1.5354911981828507,1.6978580529393024,"['IRF3', 'TRADD', 'PIN1']",0.9349406660323323,0,0,3
89,Serotonin and anxiety WP3947,0.34296948306750885,2.761969439728353,2.9556216303716596,['CRH'],0.9349406660323323,0,0,1
90,Serotonin and anxiety-related events WP3944,0.34296948306750885,2.761969439728353,2.9556216303716596,['CRH'],0.9349406660323323,0,0,1
91,ERK Pathway in Huntington's Disease WP3853,0.34296948306750885,2.761969439728353,2.9556216303716596,['HRAS'],0.9349406660323323,0,0,1
92,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.34296948306750885,2.761969439728353,2.9556216303716596,['MAFF'],0.9349406660323323,0,0,1
93,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.34296948306750885,2.761969439728353,2.9556216303716596,['MAP3K14'],0.9349406660323323,0,0,1
94,Mevalonate pathway WP3963,0.34296948306750885,2.761969439728353,2.9556216303716596,['MVK'],0.9349406660323323,0,0,1
95,Nanoparticle triggered regulated necrosis WP2513,0.34296948306750885,2.761969439728353,2.9556216303716596,['TRADD'],0.9349406660323323,0,0,1
96,Osteoclast Signaling WP12,0.34296948306750885,2.761969439728353,2.9556216303716596,['ATP6V1G1'],0.9349406660323323,0,0,1
97,Overview of nanoparticle effects WP3287,0.34296948306750885,2.761969439728353,2.9556216303716596,['BAX'],0.9349406660323323,0,0,1
98,Vitamin D-sensitive calcium signaling in depression WP4698,0.3460886944354186,1.726828231292517,1.8322686989211745,"['GPX4', 'ATP2B4']",0.9349406660323323,0,0,2
99,Disruption of postsynaptic signaling by CNV WP4875,0.3460886944354186,1.726828231292517,1.8322686989211745,"['HOMER1', 'CAMK2A']",0.9349406660323323,0,0,2
100,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3460886944354186,1.726828231292517,1.8322686989211745,"['LDHA', 'BAX']",0.9349406660323323,0,0,2
101,16p11.2 proximal deletion syndrome WP4949,0.34658601286337054,1.3820819112627987,1.4644875194200058,"['KCTD13', 'TMEM219', 'CCT7', 'CCT4']",0.9349406660323323,0,0,4
102,Insulin Signaling WP481,0.34728317166689476,1.2761854583772392,1.3497125966133316,"['XBP1', 'INSR', 'ENPP1', 'MAP3K14', 'HRAS', 'PFKM']",0.9349406660323323,0,0,6
103,AGE/RAGE pathway WP2324,0.36882955015612084,1.4292427891675967,1.4255562937287753,"['CASP9', 'INSR', 'CYCS']",0.9349406660323323,0,0,3
104,Synaptic Vesicle Pathway WP2267,0.36882955015612084,1.4292427891675967,1.4255562937287753,"['SLC32A1', 'PARK7', 'AP2M1']",0.9349406660323323,0,0,3
105,Base Excision Repair WP4752,0.3711425006739044,1.6250500200080031,1.6106995141050977,"['NEIL2', 'POLE3']",0.9349406660323323,0,0,2
106,White fat cell differentiation WP4149,0.3711425006739044,1.6250500200080031,1.6106995141050977,"['IRF3', 'DDIT3']",0.9349406660323323,0,0,2
107,Androgen receptor signaling pathway WP138,0.37801745869761394,1.3159434422233056,1.280169384728579,"['SUMO1', 'BAG1', 'PARK7', 'FKBP4']",0.9349406660323323,0,0,4
108,DNA Repair Pathways Full Network WP4946,0.3822909488650047,1.2562548562548563,1.2079811454045597,"['RFC3', 'NEIL2', 'CENPX', 'POLE3', 'GTF2H5']",0.9349406660323323,0,0,5
109,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3874091695524342,2.301358234295416,2.182317853362469,['NSDHL'],0.9349406660323323,0,0,1
110,EDA signaling in hair follicle development WP3930,0.3874091695524342,2.301358234295416,2.182317853362469,['SOSTDC1'],0.9349406660323323,0,0,1
111,Glycolysis in senescence WP5049,0.3874091695524342,2.301358234295416,2.182317853362469,['LDHA'],0.9349406660323323,0,0,1
112,HIF1A and PPARG regulation of glycolysis WP2456,0.3874091695524342,2.301358234295416,2.182317853362469,['LDHA'],0.9349406660323323,0,0,1
113,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3874091695524342,2.301358234295416,2.182317853362469,['HRAS'],0.9349406660323323,0,0,1
114,Nanoparticle triggered autophagic cell death WP2509,0.3874091695524342,2.301358234295416,2.182317853362469,['INSR'],0.9349406660323323,0,0,1
115,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.3874091695524342,2.301358234295416,2.182317853362469,['IRF3'],0.9349406660323323,0,0,1
116,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3874091695524342,2.301358234295416,2.182317853362469,['LDHA'],0.9349406660323323,0,0,1
117,RAS and bradykinin pathways in COVID-19 WP4969,0.3874091695524342,2.301358234295416,2.182317853362469,['NOS1'],0.9349406660323323,0,0,1
118,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.39580287357489163,1.534580498866213,1.4223090329996932,"['HOMER1', 'HRAS']",0.9349406660323323,0,0,2
119,Glycosylation and related congenital defects WP4521,0.39580287357489163,1.534580498866213,1.4223090329996932,"['DPAGT1', 'MAGT1']",0.9349406660323323,0,0,2
120,"GPCRs, Class A Rhodopsin-like WP455",0.3960003003491115,1.2336691086691087,1.1427974236621177,"['NPFFR1', 'GPR22', 'NPY1R', 'OR6A2', 'GPR19']",0.9349406660323323,0,0,5
121,Exercise-induced Circadian Regulation WP410,0.4062944465541743,1.3367038522833434,1.2039386086099164,"['IDI1', 'SUMO1', 'GSTP1']",0.9349406660323323,0,0,3
122,EGF/EGFR signaling pathway WP437,0.4096815436932883,1.2118758434547907,1.0814478800567129,"['NDUFA13', 'CAMK2A', 'NEDD8', 'HRAS', 'AP2M1']",0.9349406660323323,0,0,5
123,Integrated Cancer Pathway WP1971,0.42000855150984145,1.4536340852130325,1.2609987973961998,"['CASP9', 'BAX']",0.9349406660323323,0,0,2
124,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.42000855150984145,1.4536340852130325,1.2609987973961998,"['CASP9', 'NDUFA13']",0.9349406660323323,0,0,2
125,Transcription factor regulation in adipogenesis WP3599,0.42884782589509224,1.9723502304147464,1.6698965180774028,['INSR'],0.9349406660323323,0,0,1
126,Fatty acid transporters WP5061,0.42884782589509224,1.9723502304147464,1.6698965180774028,['FABP6'],0.9349406660323323,0,0,1
127,Genes targeted by miRNAs in adipocytes WP1992,0.42884782589509224,1.9723502304147464,1.6698965180774028,['TMSB4X'],0.9349406660323323,0,0,1
128,NO metabolism in cystic fibrosis WP4947,0.42884782589509224,1.9723502304147464,1.6698965180774028,['NOS1'],0.9349406660323323,0,0,1
129,Osteopontin Signaling WP1434,0.42884782589509224,1.9723502304147464,1.6698965180774028,['MAP3K14'],0.9349406660323323,0,0,1
130,RalA downstream regulated genes WP2290,0.42884782589509224,1.9723502304147464,1.6698965180774028,['HRAS'],0.9349406660323323,0,0,1
131,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.42884782589509224,1.9723502304147464,1.6698965180774028,['ANAPC11'],0.9349406660323323,0,0,1
132,Integrated breast cancer pathway WP1984,0.4368983892851066,1.1705055772852384,0.9692425623860156,"['CASP9', 'GADD45A', 'TRADD', 'BAX', 'FAU']",0.9349406660323323,0,0,5
133,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.44370832267730526,1.3807823129251702,1.122006949384463,"['IRF3', 'TRADD']",0.9349406660323323,0,0,2
134,Hepatitis B infection WP4666,0.45040498147922625,1.1508547008547008,0.9179310797702487,"['CASP9', 'IRF3', 'CYCS', 'BAX', 'HRAS']",0.9349406660323323,0,0,5
135,VEGFA-VEGFR2 Signaling Pathway WP3888,0.46595856678603054,1.0516883690134629,0.803130826801798,"['SET', 'TXN', 'ETS1', 'PDIA6', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'CCT7', 'HRAS']",0.9349406660323323,0,0,15
136,Copper homeostasis WP3286,0.46685995028092453,1.314868804664723,1.0015697006954059,"['COX17', 'ATOX1']",0.9349406660323323,0,0,2
137,Ferroptosis WP4313,0.46685995028092453,1.314868804664723,1.0015697006954059,"['GPX4', 'VDAC2']",0.9349406660323323,0,0,2
138,One-carbon metabolism and related pathways WP3940,0.46685995028092453,1.314868804664723,1.0015697006954059,"['GPX4', 'CHKA']",0.9349406660323323,0,0,2
139,Transcriptional cascade regulating adipogenesis WP4211,0.4674877915465134,1.7255942275042444,1.3121108674349298,['DDIT3'],0.9349406660323323,0,0,1
140,Type II diabetes mellitus WP1584,0.4674877915465134,1.7255942275042444,1.3121108674349298,['INSR'],0.9349406660323323,0,0,1
141,Fluoropyrimidine Activity WP1601,0.4674877915465134,1.7255942275042444,1.3121108674349298,['GGH'],0.9349406660323323,0,0,1
142,Hypertrophy Model WP516,0.4674877915465134,1.7255942275042444,1.3121108674349298,['IL1R1'],0.9349406660323323,0,0,1
143,NRF2-ARE regulation WP4357,0.4674877915465134,1.7255942275042444,1.3121108674349298,['INSR'],0.9349406660323323,0,0,1
144,Nucleotide metabolism WP404,0.4674877915465134,1.7255942275042444,1.3121108674349298,['NME2'],0.9349406660323323,0,0,1
145,SARS coronavirus and innate immunity WP4912,0.4674877915465134,1.7255942275042444,1.3121108674349298,['IRF3'],0.9349406660323323,0,0,1
146,IL-18 signaling pathway WP4754,0.47872272296079005,1.0724318553364696,0.7899894623771426,"['ARL4D', 'NACA', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'RND2']",0.9349406660323323,0,0,8
147,Myometrial relaxation and contraction pathways WP289,0.4819672939139191,1.0899873828406632,0.7955589251808186,"['IGFBP5', 'GSTO1', 'MAFF', 'CAMK2A', 'CRH', 'NOS1']",0.9349406660323323,0,0,6
148,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4894291966011099,1.2549474335188622,0.896679357547758,"['XBP1', 'DDIT3']",0.9349406660323323,0,0,2
149,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4894291966011099,1.2549474335188622,0.896679357547758,"['BANF1', 'HRAS']",0.9349406660323323,0,0,2
150,Cori Cycle WP1946,0.5035177854676832,1.5336728919071874,1.0523085572368915,['LDHA'],0.9349406660323323,0,0,1
151,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5035177854676832,1.5336728919071874,1.0523085572368915,['ENPP1'],0.9349406660323323,0,0,1
152,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5035177854676832,1.5336728919071874,1.0523085572368915,['LDHA'],0.9349406660323323,0,0,1
153,IL1 and megakaryocytes in obesity WP2865,0.5035177854676832,1.5336728919071874,1.0523085572368915,['IL1R1'],0.9349406660323323,0,0,1
154,Pregnane X receptor pathway WP2876,0.5035177854676832,1.5336728919071874,1.0523085572368915,['PSMC5'],0.9349406660323323,0,0,1
155,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5035177854676832,1.5336728919071874,1.0523085572368915,['BAX'],0.9349406660323323,0,0,1
156,Corticotropin-releasing hormone signaling pathway WP2355,0.513664584662843,1.1191122979879369,0.745535586250402,"['CASP9', 'CAMK2A', 'CRH']",0.9349406660323323,0,0,3
157,Small cell lung cancer WP4658,0.5151620274109479,1.0825135514956836,0.7180028892660902,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9349406660323323,0,0,4
158,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5327183620884042,1.1500850340136055,0.7242803063993679,"['TMSB4X', 'NOS1']",0.9349406660323323,0,0,2
159,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5327183620884042,1.1500850340136055,0.7242803063993679,"['CASP9', 'BAX']",0.9349406660323323,0,0,2
160,PPAR signaling pathway WP3942,0.5327183620884042,1.1500850340136055,0.7242803063993679,"['FABP6', 'PLTP']",0.9349406660323323,0,0,2
161,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5371138211117288,1.3801358234295416,0.8578168647940588,['IRF3'],0.9349406660323323,0,0,1
162,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5371138211117288,1.3801358234295416,0.8578168647940588,['IRF3'],0.9349406660323323,0,0,1
163,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5371138211117288,1.3801358234295416,0.8578168647940588,['NOS1'],0.9349406660323323,0,0,1
164,Neural Crest Cell Migration during Development WP4564,0.5371138211117288,1.3801358234295416,0.8578168647940588,['CDH11'],0.9349406660323323,0,0,1
165,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5371138211117288,1.3801358234295416,0.8578168647940588,['GSTP1'],0.9349406660323323,0,0,1
166,PPAR-alpha pathway WP2878,0.5371138211117288,1.3801358234295416,0.8578168647940588,['PLTP'],0.9349406660323323,0,0,1
167,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5371138211117288,1.3801358234295416,0.8578168647940588,['HRAS'],0.9349406660323323,0,0,1
168,Pancreatic adenocarcinoma pathway WP4263,0.5471307501165684,1.0614598348840256,0.640131901197501,"['CASP9', 'GADD45A', 'BAX']",0.9349406660323323,0,0,3
169,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5534022413389386,1.1039455782312926,0.6531716585736054,"['IL1R1', 'MAP3K14']",0.9349406660323323,0,0,2
170,p53 transcriptional gene network WP4963,0.5534022413389386,1.1039455782312926,0.6531716585736054,"['GADD45A', 'BAX']",0.9349406660323323,0,0,2
171,B Cell Receptor Signaling Pathway WP23,0.5633498920346149,1.0347955706984668,0.5938219561843421,"['CAMK2A', 'ETS1', 'HRAS']",0.9349406660323323,0,0,3
172,16p11.2 distal deletion syndrome WP4950,0.5684400607829453,1.254514585584195,0.7086243627897545,['INSR'],0.9349406660323323,0,0,1
173,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5684400607829453,1.254514585584195,0.7086243627897545,['HRAS'],0.9349406660323323,0,0,1
174,TLR4 Signaling and Tolerance WP3851,0.5684400607829453,1.254514585584195,0.7086243627897545,['IRF3'],0.9349406660323323,0,0,1
175,Cell migration and invasion through p75NTR WP4561,0.5684400607829453,1.254514585584195,0.7086243627897545,['CDH11'],0.9349406660323323,0,0,1
176,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5684400607829453,1.254514585584195,0.7086243627897545,['CD63'],0.9349406660323323,0,0,1
177,Methionine De Novo and Salvage Pathway WP3580,0.5684400607829453,1.254514585584195,0.7086243627897545,['TXN'],0.9349406660323323,0,0,1
178,Nanoparticle-mediated activation of receptor signaling WP2643,0.5684400607829453,1.254514585584195,0.7086243627897545,['HRAS'],0.9349406660323323,0,0,1
179,Neural Crest Cell Migration in Cancer WP4565,0.5684400607829453,1.254514585584195,0.7086243627897545,['CDH11'],0.9349406660323323,0,0,1
180,PDGFR-beta pathway WP3972,0.5684400607829453,1.254514585584195,0.7086243627897545,['HRAS'],0.9349406660323323,0,0,1
181,Allograft Rejection WP2328,0.5734302751664971,1.0613553113553114,0.5902397774932044,"['CASP9', 'HLA-B']",0.9349406660323323,0,0,2
182,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5734302751664971,1.0613553113553114,0.5902397774932044,"['BEX3', 'ETS1']",0.9349406660323323,0,0,2
183,Complement system WP2806,0.5734302751664971,1.0613553113553114,0.5902397774932044,"['RPS19', 'TXN']",0.9349406660323323,0,0,2
184,IL-1 signaling pathway WP195,0.5734302751664971,1.0613553113553114,0.5902397774932044,"['IL1R1', 'MAP3K14']",0.9349406660323323,0,0,2
185,Fragile X Syndrome  WP4549,0.585100563105743,0.985251097025841,0.5280665514828978,"['HOMER1', 'CAMK2A', 'DLGAP3', 'AP2M1']",0.9350012402204766,0,0,4
186,Pathways affected in adenoid cystic carcinoma WP3651,0.5927964955868437,1.0219198790627362,0.5343661116441494,"['SETD2', 'HRAS']",0.9350012402204766,0,0,2
187,Proximal tubule transport WP4917,0.5927964955868437,1.0219198790627362,0.5343661116441494,"['ATP6V1G1', 'ATP6V1F']",0.9350012402204766,0,0,2
188,Type II interferon signaling (IFNG) WP619,0.5976496121560441,1.149830220713073,0.591875830052825,['HLA-B'],0.9350012402204766,0,0,1
189,Heart Development WP1591,0.5976496121560441,1.149830220713073,0.591875830052825,['VEGFB'],0.9350012402204766,0,0,1
190,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5976496121560441,1.149830220713073,0.591875830052825,['B3GALT2'],0.9350012402204766,0,0,1
191,NRF2 pathway WP2884,0.6113837877246505,0.9510415440743792,0.46794133852718983,"['SLC6A16', 'GSTP1', 'MAFF', 'TXN']",0.9350012402204766,0,0,4
192,DNA damage response (only ATM dependent) WP710,0.6245576149500885,0.9402586340405761,0.44259073625679324,"['INSR', 'BAX', 'HRAS']",0.9350012402204766,0,0,3
193,Hippo-Merlin Signaling Dysregulation WP4541,0.6245576149500885,0.9402586340405761,0.44259073625679324,"['INSR', 'CDH11', 'HRAS']",0.9350012402204766,0,0,3
194,Toll-like Receptor Signaling related to MyD88 WP3858,0.6248852714301517,1.0612511427452005,0.4989867158351439,['IRF3'],0.9350012402204766,0,0,1
195,Urea cycle and associated pathways WP4595,0.6248852714301517,1.0612511427452005,0.4989867158351439,['NOS1'],0.9350012402204766,0,0,1
196,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6248852714301517,1.0612511427452005,0.4989867158351439,['HRAS'],0.9350012402204766,0,0,1
197,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6248852714301517,1.0612511427452005,0.4989867158351439,['H2AFZ'],0.9350012402204766,0,0,1
198,MAPK Cascade WP422,0.6248852714301517,1.0612511427452005,0.4989867158351439,['HRAS'],0.9350012402204766,0,0,1
199,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6248852714301517,1.0612511427452005,0.4989867158351439,['HRAS'],0.9350012402204766,0,0,1
200,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6502802168261166,0.9853262187727383,0.4240370164591247,['HRAS'],0.9350012402204766,0,0,1
201,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6502802168261166,0.9853262187727383,0.4240370164591247,['IRF3'],0.9350012402204766,0,0,1
202,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6502802168261166,0.9853262187727383,0.4240370164591247,['DDIT3'],0.9350012402204766,0,0,1
203,IL-2 signaling pathway WP49,0.6502802168261166,0.9853262187727383,0.4240370164591247,['HRAS'],0.9350012402204766,0,0,1
204,Melatonin metabolism and effects WP3298,0.6502802168261166,0.9853262187727383,0.4240370164591247,['CAMK2A'],0.9350012402204766,0,0,1
205,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6502802168261166,0.9853262187727383,0.4240370164591247,['FERMT3'],0.9350012402204766,0,0,1
206,Pathways in clear cell renal cell carcinoma WP4018,0.6528703140794051,0.8991556181023628,0.38337906782677605,"['SETD2', 'LDHA', 'PFKM']",0.9350012402204766,0,0,3
207,Sleep regulation WP3591,0.6739586553838872,0.9195246179966045,0.3628320118161621,['CRH'],0.9350012402204766,0,0,1
208,Alpha 6 Beta 4 signaling pathway WP244,0.6739586553838872,0.9195246179966045,0.3628320118161621,['HRAS'],0.9350012402204766,0,0,1
209,ATM Signaling Pathway WP2516,0.6739586553838872,0.9195246179966045,0.3628320118161621,['GADD45A'],0.9350012402204766,0,0,1
210,Target Of Rapamycin (TOR) Signaling WP1471,0.6739586553838872,0.9195246179966045,0.3628320118161621,['IDI1'],0.9350012402204766,0,0,1
211,Vitamin B12 metabolism WP1533,0.6739586553838872,0.9195246179966045,0.3628320118161621,['INSR'],0.9350012402204766,0,0,1
212,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6739586553838872,0.9195246179966045,0.3628320118161621,['IRF3'],0.9350012402204766,0,0,1
213,PDGF Pathway WP2526,0.6739586553838872,0.9195246179966045,0.3628320118161621,['HRAS'],0.9350012402204766,0,0,1
214,T-cell receptor (TCR) signaling pathway WP69,0.6797314088317583,0.8617134353741497,0.3326709740882592,"['HRAS', 'MAP3K14']",0.9350012402204766,0,0,2
215,Leptin signaling pathway WP2034,0.6797314088317583,0.8617134353741497,0.3326709740882592,"['BAX', 'HRAS']",0.9350012402204766,0,0,2
216,Amino Acid metabolism WP3925,0.69518265226709,0.8354978354978355,0.30377085356337924,"['LDHA', 'IDH1']",0.9350012402204766,0,0,2
217,ErbB signaling pathway WP673,0.69518265226709,0.8354978354978355,0.30377085356337924,"['CAMK2A', 'HRAS']",0.9350012402204766,0,0,2
218,Retinoblastoma gene in cancer WP2446,0.69518265226709,0.8354978354978355,0.30377085356337924,"['RFC3', 'H2AFZ']",0.9350012402204766,0,0,2
219,Bladder cancer WP2828,0.6960364260074948,0.8619482173174873,0.3123297670101549,['HRAS'],0.9350012402204766,0,0,1
220,Endothelin Pathways WP2197,0.6960364260074948,0.8619482173174873,0.3123297670101549,['NPY1R'],0.9350012402204766,0,0,1
221,IL17 signaling pathway WP2112,0.6960364260074948,0.8619482173174873,0.3123297670101549,['MAP3K14'],0.9350012402204766,0,0,1
222,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7048171326281716,0.8268143100511073,0.2892336156422073,"['INSR', 'MAP3K14', 'HRAS']",0.9350012402204766,0,0,3
223,Ebola Virus Pathway on Host WP4217,0.7048171326281716,0.8268143100511073,0.2892336156422073,"['IRF3', 'HLA-B', 'CLEC4G']",0.9350012402204766,0,0,3
224,Ras signaling WP4223,0.7162536012947619,0.8223727777494778,0.2744430517666492,"['GNG10', 'INSR', 'ETS1', 'HRAS']",0.9350012402204766,0,0,4
225,Aryl Hydrocarbon Receptor Pathway WP2873,0.7166215628717929,0.8111455108359134,0.27027967373882245,['BAX'],0.9350012402204766,0,0,1
226,Ethanol effects on histone modifications WP3996,0.7166215628717929,0.8111455108359134,0.27027967373882245,['SLC19A1'],0.9350012402204766,0,0,1
227,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7166215628717929,0.8111455108359134,0.27027967373882245,['HRAS'],0.9350012402204766,0,0,1
228,miRNA regulation of prostate cancer signaling pathways WP3981,0.7166215628717929,0.8111455108359134,0.27027967373882245,['CASP9'],0.9350012402204766,0,0,1
229,Pre-implantation embryo WP3527,0.7166215628717929,0.8111455108359134,0.27027967373882245,['DDIT3'],0.9350012402204766,0,0,1
230,Spinal Cord Injury WP2431,0.716834284169032,0.8105020543140595,0.26982471627793936,"['IL1R1', 'GADD45A', 'NOS1']",0.9350012402204766,0,0,3
231,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.73581481995046,0.7659875495189586,0.23498720563429956,['MAP3K14'],0.9514846809704225,0,0,1
232,Interleukin-11 Signaling Pathway WP2332,0.73581481995046,0.7659875495189586,0.23498720563429956,['HRAS'],0.9514846809704225,0,0,1
233,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7509121162403639,0.7448060305203162,0.21336209321635996,"['BAX', 'HRAS']",0.9621831844380391,0,0,2
234,Pathways Regulating Hippo Signaling WP4540,0.7509121162403639,0.7448060305203162,0.21336209321635996,"['INSR', 'CDH11']",0.9621831844380391,0,0,2
235,Cardiac Progenitor Differentiation WP2406,0.7537101611431306,0.7255830578143151,0.2051567133164236,['MESP1'],0.9621831844380391,0,0,1
236,G Protein Signaling Pathways WP35,0.7633988113643877,0.7251163623344075,0.1957630692688972,"['GNG10', 'HRAS']",0.9629940212732879,0,0,2
237,Aryl Hydrocarbon Receptor Netpath WP2586,0.7703952170186303,0.6892190152801358,0.17978390146514375,['HRAS'],0.9629940212732879,0,0,1
238,Common Pathways Underlying Drug Addiction WP2636,0.7703952170186303,0.6892190152801358,0.17978390146514375,['CAMK2A'],0.9629940212732879,0,0,1
239,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7703952170186303,0.6892190152801358,0.17978390146514375,['CASP9'],0.9629940212732879,0,0,1
240,Peptide GPCRs WP24,0.7703952170186303,0.6892190152801358,0.17978390146514375,['NPY1R'],0.9629940212732879,0,0,1
241,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.785951710962086,0.6563182148920689,0.15808075593314916,['IGFBP5'],0.9663340708550239,0,0,1
242,IL-3 signaling pathway WP286,0.785951710962086,0.6563182148920689,0.15808075593314916,['HRAS'],0.9663340708550239,0,0,1
243,Kit receptor signaling pathway WP304,0.785951710962086,0.6563182148920689,0.15808075593314916,['HRAS'],0.9663340708550239,0,0,1
244,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.785951710962086,0.6563182148920689,0.15808075593314916,['CAMK2A'],0.9663340708550239,0,0,1
245,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8004558569662574,0.6264083963574626,0.139422155004841,['MAP3K14'],0.9722135914569927,0,0,1
246,TGF-beta Receptor Signaling WP560,0.8004558569662574,0.6264083963574626,0.139422155004841,['HRAS'],0.9722135914569927,0,0,1
247,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8004558569662574,0.6264083963574626,0.139422155004841,['BAX'],0.9722135914569927,0,0,1
248,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8080486389557731,0.6557337220602527,0.1397585121348153,"['CASP9', 'HRAS']",0.9734505958932813,0,0,2
249,Vitamin D Receptor Pathway WP2877,0.808413629509772,0.688160136286201,0.14635888442537798,"['IGFBP5', 'GADD45A', 'SOSTDC1']",0.9734505958932813,0,0,3
250,Metabolic reprogramming in colon cancer WP4290,0.8139787301240359,0.5990994316084742,0.1233072701078593,['LDHA'],0.9734505958932813,0,0,1
251,Nuclear Receptors Meta-Pathway WP2882,0.8159337777005443,0.7514606560891939,0.15286369127038274,"['PSMC5', 'SLC6A16', 'GSTP1', 'MAFF', 'BAX', 'TXN', 'PLTP']",0.9734505958932813,0,0,7
252,Circadian rhythm related genes WP3594,0.8215259317485586,0.696418542359701,0.13691015784693547,"['HOMER1', 'CRH', 'RPS27A', 'UBA52']",0.9734505958932813,0,0,4
253,Metapathway biotransformation Phase I and II WP702,0.8249934164713406,0.6657965598725064,0.1280858574417154,"['GPX4', 'GSTO1', 'GSTP1']",0.9734505958932813,0,0,3
254,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8265866129711664,0.5740662139219015,0.10933123899571733,['HRAS'],0.9734505958932813,0,0,1
255,TGF-beta Signaling Pathway WP366,0.8274330065092891,0.6257730364873222,0.11853839277959399,"['SUMO1', 'ETS1']",0.9734505958932813,0,0,2
256,Breast cancer pathway WP4262,0.8328139263231095,0.6551472377707471,0.11985593731272379,"['GADD45A', 'BAX', 'HRAS']",0.9759538199098939,0,0,3
257,22q11.2 copy number variation syndrome WP4657,0.8364496726866143,0.6117913832199546,0.10925916515831179,"['RANBP1', 'MRPL40']",0.9764003961322346,0,0,2
258,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8493004877596331,0.5297766749379652,0.08653490024863096,['HRAS'],0.9829659872443072,0,0,1
259,Senescence and Autophagy in Cancer WP615,0.853215758849818,0.585612968591692,0.09296185539063674,"['IGFBP5', 'HRAS']",0.9829659872443072,0,0,2
260,Male infertility WP4673,0.853215758849818,0.585612968591692,0.09296185539063674,"['INSR', 'NOS1']",0.9829659872443072,0,0,2
261,Cardiac Hypertrophic Response WP2795,0.8595178777710502,0.5100924353895492,0.07721965683708212,['MAP3K14'],0.9829659872443072,0,0,1
262,Prader-Willi and Angelman Syndrome WP3998,0.8595178777710502,0.5100924353895492,0.07721965683708212,['SNURF'],0.9829659872443072,0,0,1
263,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8690436161466661,0.49181421295173416,0.06903200874646284,['IDI1'],0.9829659872443072,0,0,1
264,Phosphodiesterases in neuronal function WP4222,0.8690436161466661,0.49181421295173416,0.06903200874646284,['NOS1'],0.9829659872443072,0,0,1
265,Oncostatin M Signaling Pathway WP2374,0.877924449056898,0.4747965575785961,0.061816013398055564,['HRAS'],0.9829659872443072,0,0,1
266,AMP-activated protein kinase (AMPK) signaling WP1403,0.8862039682552421,0.45891341256366724,0.05544047689159173,['INSR'],0.9829659872443072,0,0,1
267,Translation Factors WP107,0.8939228235831066,0.4440549865819596,0.04979447653899216,['EEF1B2'],0.9829659872443072,0,0,1
268,Neural Crest Differentiation WP2064,0.8939228235831066,0.4440549865819596,0.04979447653899216,['ETS1'],0.9829659872443072,0,0,1
269,MAPK Signaling Pathway WP382,0.9005568985658258,0.6181566181566182,0.06474691774516067,"['IL1R1', 'GADD45A', 'DDIT3', 'HRAS', 'MAP3K14']",0.9829659872443072,0,0,5
270,G1 to S cell cycle control WP45,0.9011189213740317,0.43012521222410866,0.04478379485870481,['GADD45A'],0.9829659872443072,0,0,1
271,Chemokine signaling pathway WP3929,0.9057028056509699,0.49993815708101424,0.0495159027441192,"['GNG10', 'HRAS']",0.9829659872443072,0,0,2
272,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9078276090242514,0.4170396666152184,0.0403280595133147,['ENPP1'],0.9829659872443072,0,0,1
273,Endochondral Ossification WP474,0.9078276090242514,0.4170396666152184,0.0403280595133147,['ENPP1'],0.9829659872443072,0,0,1
274,Cell cycle WP179,0.9108662525166292,0.4909499514091351,0.045834697856902584,"['GADD45A', 'ANAPC11']",0.9829659872443072,0,0,2
275,Endoderm differentiation WP2853,0.9157639972023331,0.4822771213748657,0.04243874331195238,"['TCEAL2', 'NME1']",0.9829659872443072,0,0,2
276,Mesodermal commitment pathway WP2857,0.9157639972023331,0.4822771213748657,0.04243874331195238,"['SETD2', 'RPL38']",0.9829659872443072,0,0,2
277,Glioblastoma signaling pathways WP2261,0.9253478456676757,0.3821448783248444,0.02964892545142116,['HRAS'],0.9829659872443072,0,0,1
278,Prolactin Signaling Pathway WP2037,0.9253478456676757,0.3821448783248444,0.02964892545142116,['HRAS'],0.9829659872443072,0,0,1
279,Toll-like Receptor Signaling Pathway WP75,0.9304149900034429,0.3717707520763548,0.026813804350891583,['IRF3'],0.9829659872443072,0,0,1
280,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9304149900034429,0.3717707520763548,0.026813804350891583,['PSMC5'],0.9829659872443072,0,0,1
281,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.930682692374825,0.5956670637284097,0.04279086594777965,"['CASP9', 'GNG10', 'INSR', 'VEGFB', 'NOS1', 'HRAS']",0.9829659872443072,0,0,6
282,Adipogenesis WP236,0.932936439447977,0.45042935206869633,0.03126799726981647,"['GADD45A', 'DDIT3']",0.9829659872443072,0,0,2
283,Head and Neck Squamous Cell Carcinoma WP4674,0.935138725789553,0.36194263247252256,0.024272014406401175,['HRAS'],0.9829659872443072,0,0,1
284,Integrin-mediated Cell Adhesion WP185,0.935138725789553,0.36194263247252256,0.024272014406401175,['HRAS'],0.9829659872443072,0,0,1
285,MECP2 and Associated Rett Syndrome WP3584,0.9395422895149594,0.3526185190022202,0.02199015417958307,['CAMK2A'],0.9829659872443072,0,0,1
286,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9402263493865182,0.43602202785876254,0.026874058750673023,"['CAMK2A', 'HRAS']",0.9829659872443072,0,0,2
287,Joubert Syndrome WP4656,0.9436473477545348,0.34376061120543294,0.01993906248498603,['CEP41'],0.9829659872443072,0,0,1
288,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9436473477545348,0.34376061120543294,0.01993906248498603,['MAP3K14'],0.9829659872443072,0,0,1
289,Wnt signaling WP428,0.9574666505839421,0.3123553017440963,0.013576332094847026,['CAMK2A'],0.9934719978633374,0,0,1
290,Thermogenesis WP4321,0.9603562646012261,0.3053763440860215,0.012352764570849583,['HRAS'],0.9934719978633374,0,0,1
291,Gastrin signaling pathway WP4659,0.9655607239462692,0.2923093595347325,0.010244357212908886,['HRAS'],0.9954234267487311,0,0,1
292,ESC Pluripotency Pathways WP3931,0.9757790172626299,0.2640394410343477,0.006474018685336816,['HRAS'],0.9970088164773686,0,0,1
293,Regulation of toll-like receptor signaling pathway WP1449,0.9774259759860436,0.2590255309606945,0.005914256872565788,['IRF3'],0.9970088164773686,0,0,1
294,PI3K-Akt signaling pathway WP4172,0.9796457288648234,0.46467817896389324,0.009555769316506849,"['CASP9', 'GNG10', 'INSR', 'VEGFB', 'HRAS']",0.9970088164773686,0,0,5
295,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9803920028694125,0.24954468282142306,0.004941679544440779,['HRAS'],0.9970088164773686,0,0,1
296,Focal Adhesion WP306,0.9856391673647682,0.3148017827820783,0.004553591222207827,"['VEGFB', 'HRAS']",0.9974101698218876,0,0,2
297,Regulation of Actin Cytoskeleton WP51,0.9903092650911572,0.21089199425362412,0.0020536653238875185,['TMSB4X'],0.9974101698218876,0,0,1
298,Calcium Regulation in the Cardiac Cell WP536,0.9931891391667365,0.1957070094591317,0.0013374931332849698,['CAMK2A'],0.9974101698218876,0,0,1
299,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9940854692558146,0.19022354272778721,0.0011284233382706736,['CDCA7L'],0.9974101698218876,0,0,1
300,Ciliopathies WP4803,0.9992886251289462,0.13377609108159394,9.519881458154552e-05,['CEP41'],0.9992886251289462,0,0,1
